Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 8, 2019

View Archived Issues

A11 Mb-IRDye800CW is a promising new probe for real-time fluorescence imaging in prostate cancer

Alios BioPharma presents first-in-human data for AL-794

FEN1 and APEX2 as potential new targets in BRCA2-mutant tumors

FDA clears IND application for FT-516 cell therapy derived from an engineered pluripotent stem cell

First mouse kidneys grown from mouse stem cells in rats

Recida Therapeutics launches to develop lead program, RC-01

AAV9 vector encoding modified HEXB shows promise in vivo for Tay-Sachs disease

China's NMPA clears IND for bispecific antibody IBI-318

Targeting NRAS activator STK19 blocks melanocyte malignant transformation and melanoma growth

Interim data presented from first-in-human study of AT-GAA in patients with Pompe disease

Sanofi Genzyme presents long-term safety data for avalglucosidase alfa in Pompe disease

iVeena initiates phase I/IIa study of IVMED-80

Preliminary data presented from phase II study of MGTA-456 in inherited metabolic disorders

DSMB completes its third review of phase I/IIa study of VBI-1901 in recurrent GBM

Interim phase IIb data shows promising signs of clinical benefit for MDNA-55 in rGBM

New phase III study of empagliflozin assesses cardio-renal outcomes in chronic kidney disease

Moleculin's third drug candidate approved to enter clinical testing

Antidote Therapeutics to collaborate with NCI on development of ATI-1013

Ligand Pharmaceuticals enters OmniAb collaboration with Genagon Therapeutics

2-AG is a predictor of poor outcome in patients with aSAH

FDA clears IND for phase II study of Pulmazole in allergic bronchopulmonary aspergillosis

AbbVie patents lysophospholipid S1P5 receptor agonists

Phenex-FXR presents modulators of oxysterol receptors

Improved liver-targeted AAV gene therapy has long-lasting effects in Fabry disease model

Bayer and DKFZ jointly identify MAP4K1 inhibitors

Selection Biosciences divulges new 3-quinuclidone compounds

Chinese researchers disclose EGFR inhibitors

Sanofi to seek new partner for ophthalmology gene therapies SAR-422459 and SAR-421869

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...